BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33740045)

  • 21. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
    Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
    Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability.
    Russell H; Kedzierska K; Buchanan DD; Thomas R; Tham E; Mints M; Keränen A; Giles GG; Southey MC; Milne RL; Tomlinson I; Church D; Spurdle AB; O'Mara TA; Lewis A
    Clin Epigenetics; 2020 Jul; 12(1):102. PubMed ID: 32641106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implications of microsatellite instability and MLH1 gene inactivation in sporadic insulinomas.
    Mei M; Deng D; Liu TH; Sang XT; Lu X; Xiang HD; Zhou J; Wu H; Yang Y; Chen J; Lu CM; Chen YJ
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3448-57. PubMed ID: 19567531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia.
    Horowitz N; Pinto K; Mutch DG; Herzog TJ; Rader JS; Gibb R; Bocker-Edmonston T; Goodfellow PJ
    Gynecol Oncol; 2002 Jul; 86(1):62-8. PubMed ID: 12079302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
    Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
    Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-level microsatellite instability in appendiceal carcinomas.
    Taggart MW; Galbincea J; Mansfield PF; Fournier KF; Royal RE; Overman MJ; Rashid A; Abraham SC
    Am J Surg Pathol; 2013 Aug; 37(8):1192-200. PubMed ID: 23648460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
    Hu G; Qin L; Zhang X; Ye G; Huang T
    Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
    Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
    Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite instability, promoter methylation and protein expression of the DNA mismatch repair genes in epithelial ovarian cancer.
    V S; Bhagat R; C S P; V R P; Krishnamoorthy L
    Genomics; 2014 Oct; 104(4):257-63. PubMed ID: 25192888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability.
    Haruma T; Nagasaka T; Nakamura K; Haraga J; Nyuya A; Nishida T; Goel A; Masuyama H; Hiramatsu Y
    PLoS One; 2018; 13(4):e0195655. PubMed ID: 29659608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation.
    Kim KJ; Lee TH; Cho NY; Yang HK; Kim WH; Kang GH
    Hum Pathol; 2013 Jun; 44(6):1055-64. PubMed ID: 23266441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N_LyST: a simple and rapid screening test for Lynch syndrome.
    Susanti S; Fadhil W; Ebili HO; Asiri A; Nestarenkaite A; Hadjimichael E; Ham-Karim HA; Field J; Stafford K; Matharoo-Ball B; Hassall JC; Sharif A; Oniscu A; Ilyas M
    J Clin Pathol; 2018 Aug; 71(8):713-720. PubMed ID: 29472252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromate exposure induces DNA hypermethylation of the mismatch repair gene MLH1 in lung cancer.
    Tsuboi M; Kondo K; Soejima S; Kajiura K; Kawakita N; Toba H; Kawakami Y; Yoshida M; Takizawa H; Tangoku A
    Mol Carcinog; 2020 Jan; 59(1):24-31. PubMed ID: 31579968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation among loss of heterozygosity, promoter methylation and protein expression of MLH1 in larynx cancer.
    Smigiel R; Stembalska-Kozlowska A; Mirghomizadeh F; Krecicki T; Zatonski T; Ramsey D; Horobiowska M; Jagielski J; Blin N; Sasiadek M
    Oncol Rep; 2004 Mar; 11(3):707-10. PubMed ID: 14767526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
    Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
    Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.
    Cocco E; Benhamida J; Middha S; Zehir A; Mullaney K; Shia J; Yaeger R; Zhang L; Wong D; Villafania L; Nafa K; Scaltriti M; Drilon A; Saltz L; Schram AM; Stadler ZK; Hyman DM; Benayed R; Ladanyi M; Hechtman JF
    Cancer Res; 2019 Mar; 79(6):1047-1053. PubMed ID: 30643016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of microsatellite instability, MLH1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas among Tunisians patients.
    Kria Ben Mahmoud L; Arfaoui A; Khiari M; Chaar I; Lounis A; Sammoud S; Ben Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
    Tunis Med; 2012; 90(8-9):646-53. PubMed ID: 22987381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas.
    van Puijenbroek M; Middeldorp A; Tops CM; van Eijk R; van der Klift HM; Vasen HF; Wijnen JT; Hes FJ; Oosting J; van Wezel T; Morreau H
    Fam Cancer; 2008; 7(4):319-30. PubMed ID: 18415027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer.
    Haron NH; Mohamad Hanif EA; Abdul Manaf MR; Yaakub JA; Harun R; Mohamed R; Mohamed Rose I
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):509-517. PubMed ID: 30803214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.